Analysis & trends

6 October 2014

What qualifies as a human embryo?

Click here to read the article written by Dr. Réka Berekméri-Varró published in Budapest Business Journal (BBJ) on 6 October 2014.

News & insights

See all our News & insights

Deals & Disputes
8 January 2025

Gide advised one of the shareholders and Managing Director of the pharmaceutical group AFRIC PHAR on the sale of its stake to the Sefrioui Group

Gide’s Casablanca office advised Mr Driss Mamoun Chaoui, one of the shareholders and CEO of the Moroccan pharmaceutical group AFRIC PHAR (comprising A...

Deals & Disputes
10 December 2024

Gide advised Roquette Frères in connection with its inaugural issues of Senior and Hybrid Notes for a total amount of €1.2 Bn

Gide advised Roquette Frères, a global leader of plant-based ingredients and world-class player in pharmaceutical excipients, for the health and nutri...

Deals & Disputes
31 October 2024

Gide advises Inventiva on a multi-tranche equity financing of up to €348 million

Gide advised the biopharmaceutical company Inventiva, a company listed on Euronext Paris and Nasdaq, in an immediate financing of €94.1 million and up...

Deals & Disputes
8 October 2024

Gide advises Mérieux NutriSciences Corporation on the acquisition of Bureau Veritas’ food testing business

Gide has advised Mérieux NutriSciences Corporation on the acquisition of Bureau Veritas’ food testing business for an enterprise value of €360 m...

Deals & Disputes
20 March 2024

Gide, counsel to Cure51 on raising EUR 15 million

Gide has advised Cure51, a techbio company seeking to unlock the biological mechanisms responsible for exceptional survivors among cancer patients, on...